MedPath

Akili Interactive Labs, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

13

Active:3
Completed:10

Trial Phases

1 Phases

Not Applicable:11

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Not Applicable
11 (100.0%)

EndeavorOTC® Research Study in College Students

Not Applicable
Active, not recruiting
Conditions
Attention
Cognition
University Students
First Posted Date
2024-04-19
Last Posted Date
2024-06-27
Lead Sponsor
Akili Interactive Labs, Inc.
Target Recruit Count
69
Registration Number
NCT06376032
Locations
🇺🇸

Villa Maria College, Cheektowaga, New York, United States

🇺🇸

Landmark College, Putney, Vermont, United States

EndeavorOTC™ Prospective Product Registry

Active, not recruiting
Conditions
ADHD
First Posted Date
2023-10-31
Last Posted Date
2024-06-27
Lead Sponsor
Akili Interactive Labs, Inc.
Target Recruit Count
198
Registration Number
NCT06109051
Locations
🇺🇸

Akili Interactive Labs, Inc., Boston, Massachusetts, United States

EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")

Active, not recruiting
Conditions
ADHD
First Posted Date
2023-08-14
Last Posted Date
2024-06-27
Lead Sponsor
Akili Interactive Labs, Inc.
Target Recruit Count
150
Registration Number
NCT05991167
Locations
🇺🇸

Akili Interactive Labs, Inc., Boston, Massachusetts, United States

Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder
First Posted Date
2022-01-11
Last Posted Date
2023-02-28
Lead Sponsor
Akili Interactive Labs, Inc.
Target Recruit Count
223
Registration Number
NCT05183919
Locations
🇺🇸

Melmed Center, Scottsdale, Arizona, United States

🇺🇸

CNS Clinical Research Trials, Garden Grove, California, United States

🇺🇸

Innovative Clinical Research, Inc., Lauderhill, Florida, United States

and more 11 locations

Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder
First Posted Date
2021-05-21
Last Posted Date
2023-08-14
Lead Sponsor
Akili Interactive Labs, Inc.
Target Recruit Count
165
Registration Number
NCT04897074
Locations
🇺🇸

Melmed Center, Scottsdale, Arizona, United States

🇺🇸

Cortica, Inc., San Diego, California, United States

🇺🇸

Accel Research Sites, Maitland, Florida, United States

and more 11 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.